Novartis AG
No trades
No trades
Corporate debt securities
Below is the list of Novartis AG bonds, sorted by yield to worst. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol | YTW % | Price % | Coupon % | Maturity date | Outstanding amt | Face value | S&P rating | Fitch rating | Moody's rating | Issuer |
|---|---|---|---|---|---|---|---|---|---|---|
| NNVS6342132Novartis Capital Corp. 5.7% 18-MAR-2056 | 6.25% | 92.60% | 5.700% | 2056-03-18 | 2.25 B USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS6224266Novartis Capital Corp. 5.3% 05-NOV-2055 | 6.22% | 87.67% | 5.300% | 2055-11-05 | 550 M USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS6342130Novartis Capital Corp. 5.6% 18-MAR-2046 | 6.22% | 93.06% | 5.600% | 2046-03-18 | 1 B USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS5894401Novartis Capital Corp. 4.7% 18-SEP-2054 | 6.20% | 80.15% | 4.700% | 2054-09-18 | 750 M USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS6224265Novartis Capital Corp. 5.2% 05-NOV-2045 | 6.19% | 88.97% | 5.200% | 2045-11-05 | 350 M USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| XXPNDNovartis Capital Corp. 4.0% 20-NOV-2045 | 6.18% | 75.65% | 4.000% | 2045-11-20 | 1.25 B USD | 1,000.00 USD | AA− | AA- | — | Novartis Capital Corp. |
| UUS66989HAS7Novartis Capital Corp. 2.75% 14-AUG-2050 | 6.18% | 57.44% | 2.750% | 2050-08-14 | 1.25 B USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| UUS66989HAH1Novartis Capital Corp. 4.4% 06-MAY-2044 | 6.17% | 81.13% | 4.400% | 2044-05-06 | 1.85 B USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS3904288Novartis Capital Corp. 3.7% 21-SEP-2042 | 6.04% | 76.19% | 3.700% | 2042-09-21 | 500 M USD | 1,000.00 USD | AA− | AA- | — | Novartis Capital Corp. |
| NNVS6342131Novartis Capital Corp. 4.9% 18-MAR-2036 | 5.83% | 93.31% | 4.900% | 2036-03-18 | 2.25 B USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS6224264Novartis Capital Corp. 4.6% 05-NOV-2035 | 5.72% | 92.10% | 4.600% | 2035-11-05 | 925 M USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS6342137Novartis Capital Corp. 4.6% 18-MAR-2033 | 5.63% | 94.47% | 4.600% | 2033-03-18 | 2 B USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS5894400Novartis Capital Corp. 4.2% 18-SEP-2034 | 5.62% | 90.95% | 4.200% | 2034-09-18 | 1.1 B USD | 1,000.00 USD | AA− | AA- | — | Novartis Capital Corp. |
| NNVS6224263Novartis Capital Corp. 4.3% 05-NOV-2032 | 5.57% | 93.45% | 4.300% | 2032-11-05 | 925 M USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS6342136Novartis Capital Corp. 4.4% 18-MAR-2031 | 5.49% | 95.72% | 4.400% | 2031-03-18 | 1.75 B USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS6224251Novartis Capital Corp. 4.1% 05-NOV-2030 | 5.45% | 95.06% | 4.100% | 2030-11-05 | 1.75 B USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| UUS66989HAR9Novartis Capital Corp. 2.2% 14-AUG-2030 | 5.45% | 88.76% | 2.200% | 2030-08-14 | 1.5 B USD | 1,000.00 USD | AA− | AA- | — | Novartis Capital Corp. |
| NNVS5894399Novartis Capital Corp. 4.0% 18-SEP-2031 | 5.44% | 93.80% | 4.000% | 2031-09-18 | 850 M USD | 1,000.00 USD | AA− | AA- | — | Novartis Capital Corp. |
| NNVS5894398Novartis Capital Corp. 3.8% 18-SEP-2029 | 5.27% | 96.00% | 3.800% | 2029-09-18 | 1 B USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS6342135Novartis Capital Corp. 4.1% 16-MAR-2029 | 5.10% | 97.71% | 4.100% | 2029-03-16 | 1.25 B USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS6224255Novartis Capital Corp. 3.9% 05-NOV-2028 | 5.02% | 97.78% | 3.900% | 2028-11-05 | 700 M USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| UUS66989HAN8Novartis Capital Corp. 3.1% 17-MAY-2027 | 5.02% | 98.83% | 3.100% | 2027-05-17 | 1 B USD | 1,000.00 USD | AA− | AA- | — | Novartis Capital Corp. |
| XXS336624860Novartis Finance S.A. 4.0% 13-MAY-2041 | 4.47% | 95.09% | 4.000% | 2041-05-13 | 500 M EUR | 1,000.00 EUR | AA− | — | — | Novartis Finance SA |
| NNVS4950565Novartis Capital Corp. 2.0% 14-FEB-2027 | 4.42% | 99.09% | 2.000% | 2027-02-14 | 1.25 B USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| XXS176904160Novartis Finance S.A. 1.7% 14-AUG-2038 | 4.24% | 76.63% | 1.700% | 2038-08-14 | 750 M EUR | 1,000.00 EUR | AA− | AA- | — | Novartis Finance SA |
| XXS336624851Novartis Finance S.A. 3.5% 13-MAY-2035 | 4.22% | 94.77% | 3.500% | 2035-05-13 | 600 M EUR | 1,000.00 EUR | AA− | — | — | Novartis Finance SA |
| XXS336624827Novartis Finance S.A. 3.1% 13-JAN-2032 | 4.01% | 95.70% | 3.100% | 2032-01-13 | 600 M EUR | 1,000.00 EUR | AA− | — | — | Novartis Finance SA |
| XXS176904119Novartis Finance S.A. 1.375% 14-AUG-2030 | 3.75% | 91.58% | 1.375% | 2030-08-14 | 750 M EUR | 1,000.00 EUR | AA− | AA- | — | Novartis Finance SA |
| XXS149282548Novartis Finance S.A. 0.625% 20-SEP-2028 | 3.51% | 94.57% | 0.625% | 2028-09-20 | 500 M EUR | 1,000.00 EUR | AA− | AA- | — | Novartis Finance SA |
| NNOJANovartis Finance S.A. 1.125% 30-SEP-2027 | 3.05% | 98.12% | 1.125% | 2027-09-30 | 600 M EUR | 1,000.00 EUR | AA− | AA- | — | Novartis Finance SA |
| XXS113472979Novartis Finance S.A. 1.625% 09-NOV-2026 | 3.03% | 99.84% | 1.625% | 2026-11-09 | 600 M EUR | 1,000.00 EUR | AA− | AA- | — | Novartis Finance SA |
| 1.50% | 104.43% | 1.850% | 2040-06-18 | 280 M CHF | 5,000.00 CHF | AA− | AA- | Aa3 | Novartis AG | |
| 1.50% | 106.75% | 1.850% | 2049-06-18 | 190 M CHF | 5,000.00 CHF | AA− | AA- | Aa3 | Novartis AG | |
| 1.32% | 97.75% | 1.050% | 2035-05-11 | 325 M CHF | 5,000.00 CHF | AA− | AA- | Aa3 | Novartis AG | |
| 1.28% | 103.18% | 1.750% | 2034-06-16 | 645 M CHF | 5,000.00 CHF | AA− | AA- | Aa3 | Novartis AG | |
| 1.11% | 102.48% | 1.650% | 2031-06-18 | 435 M CHF | 5,000.00 CHF | AA− | AA- | Aa3 | Novartis AG | |
| 0.95% | 98.90% | 0.625% | 2029-11-13 | 550 M CHF | 5,000.00 CHF | AA− | AA- | Aa3 | Novartis AG | |
| 0.31% | 100.80% | 1.600% | 2027-06-18 | 650 M CHF | 5,000.00 CHF | AA− | AA- | Aa3 | Novartis AG | |
| NNVS6342134Novartis Capital Corp. FRN 16-MAR-2029 | — | 100.43% | 4.429% | 2029-03-16 | 500 M USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| NNVS6224271Novartis Capital Corp. FRN 05-NOV-2028 | — | 100.31% | 4.194% | 2028-11-05 | 800 M USD | 1,000.00 USD | AA− | — | — | Novartis Capital Corp. |
| XXS223599621Novartis Finance S.A. 0.0% 23-SEP-2028 | — | 93.00% | 0.000% | 2028-09-23 | 1.85 B EUR | 1,000.00 EUR | AA− | AA- | — | Novartis Finance SA |